CDK9-IN-19

CAT: 0804-HY-150562Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-150562Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CDK9-IN-19 is a highly potent and selective CDK9 inhibitor with an IC50 value of 2.0 nM. CDK9-IN-19 has excellent cellular antiproliferative activity, moderate pharmacokinetic property and low hERG inhibition. CDK9-IN-19 significantly induces tumour growth inhibition in an MV4-11 xenograft mice model. CDK9-IN-19 can be used for researching acute myeloid leukaemia (AML) [1].
CAS Number
[2479306-60-8]
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk9-in-19.html
Solubility
10 mM in DMSO
Smiles
O=C1C(C(C)=O)=C(N2CCOCC2)C3=C(O1)C=C(NC4=NC=C(F)C(C5=CC=C(F)C=C5OC)=N4)C=C3
Molecular Formula
C26H22F2N4O5
Molecular Weight
508.47
References & Citations
[1]Xu J, et al. Discovery of coumarin derivatives as potent and selective cyclin-dependent kinase 9 (CDK9) inhibitors with high antitumour activity. Eur J Med Chem. 2020 Aug 15;200:112424.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK9

Related Products

CatalogName
HY-176282CDK8-IN-19
HY-155966CDK2-IN-19
HY-168515CDK9-IN-35
HY-130850-01CDK9-IN-10
HY-147131-01CDK9-IN-30
HY-147026-01CDK9-IN-15
HY-153426CDK9-IN-23
HY-149641CDK9-IN-29
HY-178039CDK9-IN-42
HY-156083CDK9-IN-28

Alternative Products

CatalogName
MF-0139872-01CDK9-IN-19
521354-01CDK9
MBS9435954-01CDK9 Antibody
MBS3614751-01CDK9-IN-10
M35446-01CDK9-IN-15
M13368-01CDK9-PROTAC
C04191CDK9-IN-2
MF-0004912CDK9-IN-9
MF-0004904CDK9-IN-1
MF-0118360-01CDK9-IN-39

Popular Products